Attached files

file filename
EX-23.1 - EX-23.1 - Schrodinger, Inc.d20759dex231.htm
EX-5.1 - EX-5.1 - Schrodinger, Inc.d20759dex51.htm

As filed with the Securities and Exchange Commission on August 12, 2020.

Registration No. 333-                

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM S-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

SCHRÖDINGER, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware    2834    95-4284541

(State or other jurisdiction of

incorporation or organization)

  

(Primary Standard Industrial

Classification Code Number)

  

(I.R.S. Employer

Identification Number)

120 West 45th Street, 17th Floor

New York, New York 10036

(212) 295-5800

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

 

Ramy Farid, Ph.D.

President and Chief Executive Officer

Schrödinger, Inc.

120 West 45th Street, 17th Floor

New York, New York 10036

(212) 295-5800

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

 

Copies to:

Cynthia T. Mazareas, Esq.

Steven D. Singer, Esq.

Scott N. Lunin, Esq.

Wilmer Cutler Pickering Hale and Dorr LLP

60 State Street

Boston, Massachusetts 02109

(617) 526-6000

 

Yvonne Tran, Esq.

Executive Vice President

and Chief Legal Officer

Schrödinger, Inc.

120 West 45th Street, 17th Floor

New York, New York 10036

(212) 295-5800

 

Richard C. Segal, Esq.

Divakar Gupta, Esq.

Alison A. Haggerty, Esq.

Cooley LLP

55 Hudson Yards

New York, New York 10001

(212) 479-6000

 

 

Approximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement becomes effective.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.  ☐

If this Form is filed to register additional securities for an offering pursuant Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☒ 333-243714

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  

 

 

CALCULATION OF REGISTRATION FEE

 

 

Title of Each Class of Securities to be Registered  

Amount

to be

Registered(1)

 

Proposed

Maximum

Offering Price Per
Share(2)

 

Proposed

Maximum

Aggregate

Offering Price

 

Amount of

Registration Fee

Common Stock, par value $0.01 per share

  575,000   $66.00   $37,950,000   $4,926

 

 

(1)

Includes 75,000 shares of common stock that the underwriters have the option to purchase.

(2)

Calculated in accordance with Rule 457(a) under the Securities Act of 1933, as amended.

 

 

 


EXPLANATORY NOTE AND INCORPORATION BY REFERENCE

This registration statement is being filed with respect to the registration of additional shares of common stock, par value $0.01 per share, of Schrödinger, Inc., a Delaware corporation, pursuant to Rule 462(b) under the Securities Act of 1933, as amended. The contents of the earlier registration statement on Form S-1 (File No. 333-243714), which was declared effective by the Commission on August 12, 2020, are incorporated in this registration statement by reference.

The required opinions and consents are listed on an Exhibit Index attached hereto and filed herewith.



SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on this 12th day of August, 2020.

 

SCHRÖDINGER, INC.
By:  

/s/ Ramy Farid

 

Ramy Farid, Ph.D.

President and Chief Executive Officer

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

  

Date

/s/ Ramy Farid

   President and Chief Executive Officer, Director    August 12, 2020
Ramy Farid, Ph.D.    (Principal Executive Officer)

/s/ Joel Lebowitz

   Chief Financial Officer    August 12, 2020
Joel Lebowitz    (Principal Financial Officer)

/s/ Jenny Herman

   Vice President, Controller    August 12, 2020
Jenny Herman    (Principal Accounting Officer)

*

   Chairman of the Board    August 12, 2020
Michael Lynton

*

   Director    August 12, 2020
Jeffrey Chodakewitz, M.D.

*

   Director    August 12, 2020
Richard Friesner, Ph.D.

*

   Director    August 12, 2020
Gary Ginsberg

*

   Director    August 12, 2020
Rosana Kapeller-Libermann, M.D., Ph.D.

*

   Director    August 12, 2020
Gary Sender

*

   Director    August 12, 2020
Nancy Thornberry


*

   Director    August 12, 2020
Timothy Wright, M.D.

 

*By:  

/s/ Ramy Farid

 

Ramy Farid

 

Attorney-in-fact